MDS Virtual Congress 2021 » Parkinson's Disease: Non-Motor Symptoms

Meeting: MDS Virtual Congress 2021

A corneal nerve density possible progression biomarker in Parkinson’s disease (PD) patients: pilot study

S. Yaisawang, J. Sringean, N. Kasetsuwan, R. Bhiyasiri (Bangkok, Thailand)

A53T-SNCA-BAC transgenic mouse exhibits multiple prodromal symptoms of Parkinson’s disease: Gastrointestinal dysfunction, hyposmia and RBD-like behavior.

T. Taguchi, M. Ikuno, H. Yamakado, R. Takahashi (Kyoto, Japan)

Analysis of Sleep Structure and EEG Characteristics of Patients with Dyskinesia in Parkinson’s Disease

YM. Wang, CJ. Mao (Soochow, China)

Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy.

O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, I. Buzaev, A. Saveliev, N. Mukhamadeeva, G. Akhmadeeva (Ufa, Russian Federation)

Autonomic dysfunction in patients with Parkinson’s disease

B. Douma, I. Bedoui, M. Elfekih, H. Derbali, M. Messelmani, A. Riahi, M. Mansour, J. Zaouali, R. Mrissa (Sousse, Tunisia)

Autonomic Symptoms as Predictors of Quality of Life in Parkinson’s Disease: A 5-year follow up study

A. Bougea, S. Pantinaki, A. Antonoglou, P. Giannaki, F. Efthymiopoulou (Athens, Greece)

Back pain in Parkinson’s disease: an underestimated problem

B. Douma, I. Bedoui, M. Elfekih, H. Derbali, A. Riahi, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Sousse, Tunisia)

Behavioral effects of stimulated dopamine release and D2-like receptor displacement in Parkinson’s patients with impulse control disorder

S. Lee, M. Aumann, A. Song, K. Hay, P. Diaz, Y. Yan, H. Kang, D. Claassen (Nashville, USA)

Brain MRI morphological changes in different self-reported sleep disturbances in PD patients

X. Ma, W. Su, H. Chen (Beijing, China)

Can we predict the development of REM sleep behavior disorder (RBD) in military veterans with Parkinson’s disease?

A. Sarwar (Houston, USA)

Clinical characteristics and factors associated musculoskeletal pain in Parkinson’s disease: A retrospective study from two centers in China

J. Li, B. Zhu, Z. Gu, H. Zhang, S. Liu, S. Mei, S. Ji, H. Chen, E. Xu, P. Chan (Hefei, China)

CLINICAL CHARACTERISTICS OF PARKINSON’S DISEASE WITH PROBABLE RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER

S. Marisdina, A. Afriani, M. Mukhlisa, S. Handayani, O. Tambun, R. Nindela, Y. Diansari (Palembang, Indonesia)

Clinical Features Associated with Dysautonomia in Prodromal Parkinson’s Disease

C. Miller-Patterson, J. Hsu, J. Morley, A. Siderowf, A. Willis (Philadelphia, USA)

Clinical predictors of impulsive and compulsive behavior after subthalamic stimulation in Parkinson’s disease

A. Sauerbier, P. Loehrer, S. Jost, S. Heil, J. Petry-Schmelzer, J. Herberg, P. Bachon, S. Aloui, A. Gronostay, L. Klingelhoefer, J. Baldermann, D. Huys, C. Nimsky, M. Barbe, G. Fink, P. Martinez-Martin, K. Chaudhuri, V. Visser-Vandewalle, L. Timmermann, D. Weintraub, H. Dafsari (Cologne, Germany)

Cognitive complaints, anxiety, depression and reporting of pain in Parkinson’s Disease in a multi-ethnic population: Dissimilarities between White and Non-White patients

K. Rukavina, L. Batzu, M. Krbot Skoric, J. Staunton, A. Sauerbier, J. Ocloo, O. Awogbemelia, D. Trived, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

Comparison of gastrointestinal transit times in typical and erratic levodopa-responders in patients with Parkinson’s disease.

D. Safarpour, B. Brumbach, M. Arena, J. Quinn, J. Nutt, R. Pfeiffer (Portalnd, USA)

Conception of a sensor- and home-based measurement of camptocormia

R. Wolke, K. Naderi Beni, H. Wolframm, R. Rieger, N. Margraf (Kiel, Germany)

COVID-19 PANDEMIC: SYMPTOMS PERCEPTIONS FROM PARKINSON’S DISEASE PATIENTS

A. Braga, L. Brito, F. Rolim, P. Andrade, A. Marinho, A. Moura, H. Freitas, I. Nobrega, I. Dantas, F. Carvalho (Fortaleza, Brazil)

Data-driven prediction of fatigue in Parkinson’s disease patients

DG. Lee, M. Mirian, L. Adrian, A. Yu, S. Neilson, K. Sundvick, E. Golz, L. Folger, S. Appel-Cresswell (Vancouver, Canada)

Deterioration in oral health status potentially associated with apomorphine pump initiation: a case report

M. Auffret, V. Mathaut-Malefant, V. Denys, M. Tra, E. Boyer, V. Meuric, M. Bonnaure-Mallet, M. Vérin (Rennes, France)

Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease

H. Jackson, J. Anzures-Cabrera, T. Simuni, R. Postuma, G. Pagano (Welwyn Garden City, United Kingdom)

Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.

A. Nikitina, D. Degterev (Moscow, Russian Federation)

Dysphagia risk, respiratory muscle strength and maximal phonation time in elderly with Parkinson Disease in the initial stages

R. Gonçalves, T. de Freitas, N. de Souza, J. Veras, J. Barbosa Neto, C. Araújo, C. Do Amaral, D. Dalles, L. Cardoso, P. Cortez, E. Andrade, M. Cardoso (Manaus, Brazil)

ECHOCARDIOGRAPHY FINDINGS IN PARKINSON’S DISEASE

R. Erol Yildiz, G. Yuksel, H. Tireli (Istanbul, Turkey)

Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms including Sleep: Results from a Meta-Analysis with 24-month follow-up

K. Chaudhuri, A. Antonini, R. Pahwa, P. Odin, N. Titova, S. Thakkar, S. Snedecor, S. Hegde, A. Alobaidi, Y. Jalundhwala, J. Parra, C. Zadikoff, L. Bergmann, D. Standaert (London, United Kingdom)

Effects of Parkinson’s disease on blur-driven and disparity-driven vergence eye movements

P. Gupta, S. Beylergil, J. Murray, A. Shaikh, F. Ghasia (Cleveland, USA)

Effects of psychiatric tests on disease severity and nonmotor symptoms in early onset Parkinson’s Disease

A. Tuncer, G. Yuksel, B. Hasırcı (İstanbul, Turkey)

Evaluating the Relationship between Apathy and Grit as it Relates to Participation in a Community Exercise Program in the Population with Parkinson’s Disease.

E. Kiernan (Gainesville, USA)

Evidence of Overlapping Pathology between Depression and Autonomic Dysfunction in Parkinson’s Disease

M. Sklerov, E. Dayan, N. Browner, D. Rubinow, F. Frohlich (Chapel Hill, USA)

Exploring the usefulness of Repetitive Transcranial Magnetic Stimulation for treatment of pain and fatigue in Parkinson’s disease

A. Latorre, L. Rocchi, N. Manzo, J. Rothwell, K. Bhatia (London, United Kingdom)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy

JW. Hor, ES. Khor, KK. Chong, SL. Song, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

Functional Constipation in Parkinson’s Disease

S. Pavan, M. Ballal, A. Prabhu, S. Gorthi, B. Das, A. Mutreja, T. Ramamurthy, A. Pai (Manipal, India)

Gait impairment as predictor of falls in patients with early Parkinson’s disease

I. Stankovic, V. Markovic, S. Radovanovic, I. Petrovic, N. Dragasevic, M. Svetel, E. Stefanova, V. Kostic (Belgrade, Serbia)

GASTROINTESTINAL SYMPTOMS ARE ASSOCIATED WITH LEFT PREDOMINANT DOPAMINE TRANSPORTER BINDING DEFICIT IN PARKINSON´S DISEASE

K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, R. Levo, T. Nojonen, M. Eklund, S. Nuuttila, K. Lindholm, E. Pekkonen, J. Joutsa, T. Noponen, T. Ihalainen, V. Kaasinen, F. Scheperjans (Helsinki, Finland)

Hearing Impairment was not associated with Dream Enactment Behavior and Parkinsonism in the Population: a CLSA Prospective Study

C. Yao, A. Szpindel, A. Pelletier, R. Postuma (Montréal, Canada)

Humor processing is affected by Parkinson’s disease and levodopa

M. Prenger, K. van Hedger, K. Seergobin, A. Owen, P. Macdonald (London, Canada)

Hyperhidrosis in Parkinson’s disease: a 3-year prospective cohort study

JY. Lin, RW. Ou, QQ. Wei, CY. Li, HF. Shang (Chengdu, China)

Idiopathic Parkinson’s disease and Sensory disorders: A complication of dopatherpy or an intrinsic feature of the disease?

S. Laroussi, N. Farhat, S. Sakka, R. Boukhdhir, H. Zouari, M. Damak, C. Mhiri (Sfax, Tunisia)

Impact of COVID-19 pandemic on development of chronic stress syndromes in patients with Parkinson’s Disease : preliminary results

C. Pauly, M. Hansen, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N. Diederich (Esch-Sur-Alzette, Luxembourg)

Implementing Systematic Screening and a Treatment Algorithm for Depression in Parkinson’s Disease

C. Marras, A. Naito, J. Beck, R. de Leon, A. Allen, E. Nelson, D. Weintraub, S. Luo, S. Mantri, M. Neault (Toronto, Canada)

Improvement of excessive daytime sleepiness with low frequency repetitive transcranial magnetic stimulation in Parkinson’s disease: a preliminary sham-controlled study

S. Zhuang, JJ. Wu, X. Gu, LX. Wang, XY. Zhang, CJ. Mao, J. Chen, CF. Liu (Suzhou, China)

Impulse control disorders in idiopathic REM sleep behaviour disorder and drug-naive Parkinson’s disease

A. Otaiku (Birmingham, United Kingdom)

Increased non-motor impairment in Parkinson’s disease with REM-Sleep behaviour disorder; cross-sectional analysis in Luxembourg Parkinson’s Study

L. Pavelka, A. Rauschenberger, P. May, S. Pachchek, Z. Landoulsi, L. Pauly, D. Mcintyre, E. Glaab, R. Krüger (Belvaux, Luxembourg)

Intermittent theta burst stimulation over primary motor cortex ameliorates physical fatigue in Parkinson’s disease patients

J. Gómez-Feria, S. Blanco-Trejo, S. Jesús, L. Chirosa-Rios, I. Chirosa-Rios, JF. Martín-Rodríguez, P. Mir (Sevilla, Spain)

Is dopamine replacement therapy an addictive drug?

V. Fleury, E. Pirondini, C. Provins, D. Benis, D. Vandeville, P. Krack (Geneva, Switzerland)

IS FATIGUE ASSOCIATED WITH BALANCE IN PARKINSON’S DISEASE?

M. Terra, I. Caramaschi, H. Araújo, R. de Souza, T. da Silva, T. Nascimento, V. Probst, S. Smaili (Londrina Pr, Brazil)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease; role for cholinergic transmission?

R. Cerroni, A. Viziano, A. Stefani, R. Sisto (Rome, Italy)

Leg muscle contractions compensate for declining cardiac baroreflex in PD Patients

A. Huether, R. Fadil, R. Brunnemer, T. Harlow, A. Stutz, S. Matcha, A. Hanson, A. Blaber, K. Tavakolian, J-S. Lou (Fargo, USA)

Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease

C. Catiul, R. Memon, A. Memon, A. Joop, J. Pilkington, K. Wood, A. Amara (Birmingham, USA)

Locus coeruleus volume is reduced in Parkinson disease-related orthostatic hypotension.

P. Beach, N. Kurra, K. Hwang, J. Langley, X. Hu, D. Huddleston (Atlanta, USA)

Maintenance of physical activity (PA) mitigates worsening of patient-reported outcomes in Parkinson’s disease (PD) during the COVID-19 pandemic

J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)

Mapping intrinsically photosensitive retinal ganglion cells (ipRGCs) dysfunction in patients with Parkinson disease using Chromatic pupilloperimetry

T. Fay-Karmon, D. Jaber, I. Sher, S. Zorani, A. Bleterman, Y. Rotenstreich, S. Hassin-Baer (Ramat Gan, Israel)

Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.

D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, J. García Moreno, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín, C. Coppadis (A Coruña, Spain)

Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.

L. Jaffe (Honolulu, USA)

Non-Motor Symptoms Progression After 2 years Follow-up in Parkinson´s Disease. Results from the COPPADIS Cohort and Comparison with a Control Group

C. Cores Bartolomé, D. García, T. Fonticoba, C. Miró, E. Castro, JM. Gonzalez, S. Maestre, M. Aguilar, P. Pastor, L. Planellas Giné, M. Cosgaya, J. Garcia Caldentey, N. Caballol Pons, I. Legarda Ramirez, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila, MJ. Catalan Alonso, V. Nogueira, V. Puente, JM. Garcia Moreno, C. Borrue Fernandez, B. Solano Vila, M. Alvarez Sauco, L. Vela Desojo, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, N. Lopez Ariztegui, I. Gaston Zubimendi, J. Kulisevsky, M. Blazquez Estrada, M. Seijo Martinez, J. Ruiz Martinez, C. Valero Merino, M. Kurtis, O. de Fábregues-Boixer, J. Gonzalez Ardura, CM. Ordas Bandera, L. Lopez Diaz, P. Mir Rivera, P. Martinez Martin (A Coruña, Spain)

Nonmotor effects of subthalamic stimulation in Parkinson’s disease motor subtypes

S. Jost, A. Konitsioti, P. Loehrer, K. Ashkan, A. Rizos, A. Sauerbier, M. Ghilardi, F. Rosenkranz, L. Strobel, A. Gronostay, M. Barbe, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Ray Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)

Obstructive sleep apnea and other vascular risk factors’ impact on Non-motor Symptoms in Parkinson’s Disease

B. Meira, M. Fernandes, M. Salavisa, M. Saraiva, L. Conceiçao, C. Borbinha, F. Ladeira, JP. Marto, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

ON/OFF Blood Pressure Fluctuation in Parkinson’s Disease

K. Chung, B. Lobb (Portland, USA)

PARKINSON’S DISEASE AND COVID-19 PANDEMIC: MODIFICATIONS IN MOTOR AND NON-MOTOR SYMPTOMS AND IN THE ACCESS TO MEDICAL AND NON-MEDICAL CONSULTATIONS AND TREATMENTS

J. Bestoso, C V. Stefani, L. Ciancaglini, D. Bauso (Buenos Aires, Argentina)

Peripheral neuromodulation for the treatment of bladder symptoms associated with Parkinson’s disease

M. Smith, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

Physical activity (PA), patient reported outcomes and quality of life in Parkinson’s disease( PD)

J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)

Physical and mental fatigue in Parkinson’s Disease: analysis from COPPADIS database

MI. Morales-Casado, N. López-Ariztegui, A. Oliviero, V. Soto-León, JC. Segundo-Rodríguez, T. Deus Fonticoba, S. Jesús, M. Aguilar, P. Pastor, LL. Planellas, M. Cosgaya, J. García-Caldentey, N. Caballol, B. Vives, J. Hernández-Vara, I. Cabo, L. López-Manzanares, I. González-Aramburu, MA. ávila-Rivera, MJ. Catalán, V. Nogueira, V. Puente, M. Ruíz-de Arcos, C. Borrué, B. Solano-Vila, M. álvarez-Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo-Padilla, JC. Martínez-Castrillo, P. Sánchez-Alonso, MG. Alonso-Losada, P. Clavero, J. Kulisevsky, M. Blázquez-Estrada, M. Seijo, J. Ruíz-Martinez, C. Valero, M. Kurtis, O. de Fábregues, J. González-Ardura, C. Ordás, L. López-Díaz, P. Mir, P. Martínez-Martín, D. Santos-García, C. Study Group (Toledo, Spain)

Plasma Neurofilament Light Chain Level and Orthostatic Hypotension in Early Parkinson Disease

DG. Park, JW. Kim, Y-S. An, J. Chang, JH. Yoon (Suwon, Republic of Korea)

Predictive value of UPSIT subsets in prodromal Parkinson disease

P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelphia, USA)

Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.

D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, LL. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, M. de Arcos, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, E. Erro, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín (A Coruña, Spain)

Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

P. Beach, J. Mckay (Atlanta, USA)

Progression of neuroinflammation in patients with isolated REM sleep behavior disorder. A 11C-PK11195 PET study

A. Baun, K. Stær, A. Iranzo, M. Stokholm, K. østergaard, M. Serradell, M. Otto, K. Svendsen, A. Garrido, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus, Denmark)

Relationship between frequency and severity of REM sleep behavior disorder and clinical features in patients with Parkinson’s disease

JY. Wang, Y. Shen, CF. Liu (Suzhou, China)

Relationship between low back pain-related disability and motor performance in people with Parkinson disease

R. Duncan, K. Rawson, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, M. Lavalley, T. Nordahl, M. Saint-Hillaire, C. Thomas, J. Zajac, T. Ellis, G. Earhart (Saint Louis, USA)

Self perceived impact of the SARS-COV 2 pandemic on motor, non motor and affective symptoms in Parkinson’s disease and parkinsonisms.

A. Ranghetti, V. Cereda, R. Maestri, C. Siri, M. Canesi (Gravedona Ed Uniti, Italy)

Serial olfactory testing for the diagnosis of prodromal Parkinson disease in the Parkinson Associated Risk Syndrome (PARS) study

P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelpiha, USA)

Smell dysfunction correlates with severity of motor deficits in H&Y stage-I early onset Parkinson’s disease

J. Wang, R. Stanford, Q. Yang, L. Spreen, M. Wang, B. Mullen, K. Venkiteswaran, T. Subramanian (Hershey, USA)

Social support moderates the burden of nonmotor but not motor symptoms among patients with Parkinson’s disease

HJ. Yang, A. Kim, BS. Park (Ulsan, Republic of Korea)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction

E. Contaldi, L. Magistrelli, I. Campini, C. Comi (Novara, Italy)

THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)

The effect of deep brain stimulation on impulse control related disorders in Parkinson’s disease – a retrospective review of 137 patients

H. Shepherd, S. Healy, N. Mooney, A. da Costa, M. Bonello, D. Damodaran, J. Panicker, B. Hammersley, J. Somerset, P. Eldridge, J. Osman-Farah, S. Alusi, A. Macerollo (Liverpool, United Kingdom)

The effect of exercise on pain in Parkinson’s disease: a systematic review

V. Nguy, F. Pourkazemi, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

The experience of respiratory symptoms and the impact in daily live in patients with Parkinson’s disease: a grounded theory approach

VA. Wetering, MJ. Nijkrake, N. Koenders, PJ. Wees, BR. Bloem, JG. Kalf (Nijmegen, Netherlands)

The Impact of Back and Neck Pain in Parkinson’s Disease: The PD-PAIN Study

D. Shpiner, T. Rundek, H. Li, I. Haq, C. Luca, J. Margolesky, H. Moore, C. Singer (Miami, USA)

The impact of fatigue and pain on functional mobility, fear of falling, and falls in Individuals with Parkinson’s disease

N. Alissa, H. Khalil, A. Al-Sharman, I. E'Leimat, M. Al-Qawasmeh, K. El-Salem (Baltimore, USA)

Visual Impairment along Parkinsonism Development and the Association to Non-vision dependent Cognitive Decline: A Prospective Nation-wide CLSA study

C. Yao, A. Szpindel, S. Fereshtehnejad, A. Pelletier, C. Wolfson, R. Postuma (Montréal, Canada)

Vitamin D and Parkinson’s disease

D. Novotnyy (Novosibirsk, Russian Federation)

What predicts RBD in PD patients: video-polysomnographycally supported data from advanced, fluctuating Parkinson’s disease?

ML. Muntean, F. Sixel-Döring, D. Peterson, A. Leha, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

« View all sessions from the MDS Virtual Congress 2021.